Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 673-684 of 4,306
Drug study icon
CompletedNCT00141479

Impact of Treatment Interruption on Re-initiation of Bifeprunox

This summary needs review. Please check the official study record and contact the research team for details.

In Wichita
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Solvay Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT00492349

Varenicline Adjunctive Treatment in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT00727103

Varenicline Treatment in Alcohol and Nicotine Dependent people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Syracuse
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AddictionDrugFrom 18 Years to 69 Years
Countries
United States
Sponsor
State University of New York - Upstate Medical University
Condition
Schizophrenia, Addiction
Behavioral study icon
CompletedNCT04251195

Verbal Memory Training Using Virtual Reality in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Ottawa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 20 Years to 60 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Schizophrenia
Device study icon
Not recruitingISRCTN17308399

The gameChange study: automated virtual reality therapy to help people with psychosis feel more confident in everyday situations

This study is looking at whether a digital support tool can help people with Clinical diagnosis of schizophrenia spectrum psychosis or an affective diagnosis with psychotic symptoms, self-reported difficulties going outside the home primarily due to anxiety, Mental and Behavioural Disorders, or Schizophrenia, schizotypal and delusional disorders Bipolarity, current episode manic with psychotic symptoms Bipolarity, current episode severe depression with psychotic symptoms Severe depressive episode with psychotic symptoms Recurrent depression, current episode severe with psychotic symptoms. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Depression, ...Other
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia, Depression, ...
Behavioral study icon
CompletedNCT01321177

An Integrated Program for First Episode of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Fernando
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01216891

Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 15 Years to 35 Years
Countries
United States
Sponsor
Research Foundation for Mental Hygiene, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT07038876

ML-007C-MA for schizophrenia

This study is completed in the United States. It is testing ML-007C-MA for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.